REVLIMID: R-Squared Website

REVLIMID plus RITUXIMAB is a new FDA-approved combination therapy called R-Squared. It is used to treat follicular and marginal zone lymphoma. I wrote (and annotated) the R-Squared patient website. To see the full site visit: https://revlimid.com/rrfl/

↑Back to Top